Cargando…

Management of allergic rhinitis with leukotriene receptor antagonists versus selective H1-antihistamines: a meta-analysis of current evidence

BACKGROUND: Inconsistencies remain regarding the effectiveness and safety of leukotriene receptor antagonists (LTRAs) and selective H1-antihistamines (SAHs) for allergic rhinitis (AR). A meta-analysis of randomized controlled trials (RCTs) was conducted to compare the medications. METHODS: Relevant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yan, Meng, Ya-Ping, Dong, Ying-Ying, Qiu, Chang-Yu, Cheng, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243504/ https://www.ncbi.nlm.nih.gov/pubmed/34187561 http://dx.doi.org/10.1186/s13223-021-00564-z

Ejemplares similares

The Efficacy and Safety of Selective H(1)-Antihistamine versus Leukotriene Receptor Antagonist for Seasonal Allergic Rhinitis: A Meta-Analysis
por: Xu, Yu, et al.
Publicado: (2014)

Efficacy and anti-inflammatory analysis of glucocorticoid, antihistamine and leukotriene receptor antagonist in the treatment of allergic rhinitis
por: Qiu, Chen, et al.
Publicado: (2023)

170 Combination of a Nasal Antihistamine Olopatadine and A Leukotriene Receptor Antagonist Montelukast Sodium for the Treatment of Seasonal Allergic Patients not Currently Controlled on Monotherapy Intranasal Antihistamine or a Leukotriene Receptor Antagonist
por: Nsouli, Safa
Publicado: (2012)

Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia
por: Recto, Marysia Tiongco, et al.
Publicado: (2017)

VAS for assessing the perception of antihistamines use in allergic rhinitis
por: Giorgio, Ciprandi, et al.
Publicado: (2019)

Managing Co-Morbid Asthma With Allergic Rhinitis: Targeting the One-Airway With Leukotriene Receptor Antagonists
por: Valovirta, Erkka
Publicado: (2012)

Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties
por: Kawauchi, Hideyuki, et al.
Publicado: (2019)

Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis
por: Peters-Golden, M, et al.
Publicado: (2006)

CSACI position statement: Newer generation H(1)-antihistamines are safer than first-generation H(1)-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria
por: Fein, Michael N., et al.
Publicado: (2019)

Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review
por: Di Lorenzo, Gabriele, et al.
Publicado: (2008)

236 H1 Antihistamines Influence on Pro-inflammatory Cytokines Level in Patients With Allergic Rhinitis
por: Bocsan, Ioana Corina, et al.
Publicado: (2012)

How Could We Influence Systemic Inflammation in Allergic Rhinitis? The Role of H1 Antihistamines
por: Muntean, Ioana Adriana, et al.
Publicado: (2018)

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
por: Wang, Xue Yan, et al.
Publicado: (2016)

The Role of Antihistamines in the Treatment of Vasomotor Rhinitis
por: Lieberman, Phil
Publicado: (2009)

Prescription Profile and Clinical Outcomes in Patients with Allergic Rhinitis Treated with Oral Antihistamines or Nasal Corticosteroids
por: Sánchez, Guillermo, et al.
Publicado: (2019)

Intranasal antihistamines and corticosteroids in the treatment of allergic rhinitis: a systematic review and meta-analysis protocol
por: Sousa-Pinto, Bernardo, et al.
Publicado: (2023)

Reasons for prescribing second generation antihistamines to treat allergic rhinitis in real-life conditions and patient response
por: Demoly, Pascal, et al.
Publicado: (2014)

Leukotriene Antagonists in Dermatology
por: Bubna, Aditya Kumar
Publicado: (2021)

Intradermal Allergen Immunotherapy for Allergic Rhinitis: Current Evidence
por: Atipas, Kawita, et al.
Publicado: (2022)

Efficacy of different oral H(1) antihistamine treatments on allergic rhinitis: a systematic review and network meta-analysis of randomized controlled trials
por: Hong, Dongdong, et al.
Publicado: (2023)

Correlations of nasal responses to leukotriene D4 and histamine nasal provocation with quality of life in allergic rhinitis
por: Zhu, Zheng, et al.
Publicado: (2016)

A randomized controlled phase II clinical trial comparing ONO‐4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis
por: Okubo, K., et al.
Publicado: (2017)

Effects of bepotastine, a nonsedating H1-antihistamine, for the treatment of persistent cough and allergic rhinitis: a randomised, double-blind, placebo-controlled trial
por: Lee, Ji-Hyang, et al.
Publicado: (2023)

Identification of Allergic Disease Among Users of Antihistamines
por: Szeinbach, Sheryl L., et al.
Publicado: (2004)

Are Markers of Allergic Inflammation in Grass Pollen Allergy Influenced by H1 Antihistamines?
por: Bocsan, Ioana Corina, et al.
Publicado: (2021)

H(1 )Antihistamines: Current Status and Future Directions
por: Simon, F Estelle R, et al.
Publicado: (2008)

Cysteinyl leukotriene receptor antagonist regulates allergic airway inflammation in an organ- and cytokine-specific manner
por: Kawano, Tetsuya, et al.
Publicado: (2014)

Individualized treatment for allergic rhinitis based on key nasal clinical manifestations combined with histamine and leukotriene D4 levels()
por: Shen, Congxiang, et al.
Publicado: (2018)

Allergic rhinitis: evidence for impact on asthma
por: Thomas, Mike
Publicado: (2006)

Impact of acupuncture on antihistamine use in patients suffering seasonal allergic rhinitis: secondary analysis of results from a randomised controlled trial
por: Adam, Daniela, et al.
Publicado: (2018)

Effects of a dual CCR3 and H(1)-antagonist on symptoms and eosinophilic inflammation in allergic rhinitis
por: Greiff, Lennart, et al.
Publicado: (2010)

Cysteinyl–leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics
por: van der Burg, Nicole, et al.
Publicado: (2022)

Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: A real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS)()
por: Bian, Sainan, et al.
Publicado: (2021)

Dual systemic allergic rhinitis and local allergic rhinitis
por: Blanca, Miguel, et al.
Publicado: (2015)

H1 antihistamines and driving
por: Florin-Dan, Popescu
Publicado: (2008)

New antihistamines – perspectives in the treatment of some allergic and inflammatory disorders
por: Tatarkiewicz, Jan, et al.
Publicado: (2018)

Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria
por: Wolthers, Ole D.
Publicado: (2013)

148 Levels of F VCAM and ICAM in Patients With Allergic Rhino-Conjunctivitis and H1 Antihistamines
por: Bujor, Ioana Adriana, et al.
Publicado: (2012)

Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)

Mechanism and clinical evidence of immunotherapy in allergic rhinitis
por: De Carli, Marco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mbg2gkpopq2m0spvo0o78jmdbt